Orchid Pharma Limited (BOM:524372)
India
· Delayed Price · Currency is INR 810.85
+0.85 (0.10%)
At close: Apr 23, 2025
Orchid Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | - | 921.67 | 463.18 | -19.51 | -1,165 | -1,311 | Upgrade
|
| Depreciation & Amortization | - | 321.07 | 547.79 | 869.93 | 1,089 | 1,179 | Upgrade
|
| Other Amortization | - | 11.31 | 0.08 | 0.31 | 0.32 | 0.27 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 1.88 | -399.85 | -0 | 0.65 | -0.88 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -0.15 | -5.12 | -19.42 | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | 28.98 | 21.54 | 35.23 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | -2.65 | 11.88 | 36.67 | 13.28 | 26.65 | Upgrade
|
| Other Operating Activities | - | 56.05 | 329.54 | 298.27 | 611.43 | 214.9 | Upgrade
|
| Change in Accounts Receivable | - | 196.47 | -416.54 | -229.19 | -820.25 | 440.11 | Upgrade
|
| Change in Inventory | - | -354.88 | -560.82 | 25.37 | -334.99 | 140.63 | Upgrade
|
| Change in Accounts Payable | - | 548.51 | 139.14 | 473.63 | 179.31 | 76.92 | Upgrade
|
| Change in Other Net Operating Assets | - | -468.48 | 47.59 | 325.86 | 606.33 | -38.81 | Upgrade
|
| Operating Cash Flow | - | 1,260 | 183.38 | 924.75 | 235.86 | 808.03 | Upgrade
|
| Operating Cash Flow Growth | - | 587.05% | -80.17% | 292.07% | -70.81% | 571.99% | Upgrade
|
| Capital Expenditures | - | -648.15 | -849.13 | -144.04 | -6.04 | -42.42 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 585.46 | 0.99 | 2.86 | - | Upgrade
|
| Divestitures | - | - | - | 1,594 | - | - | Upgrade
|
| Investment in Securities | - | -2,592 | -53.07 | -326.55 | 668.52 | 1,472 | Upgrade
|
| Other Investing Activities | - | 120.02 | 4.61 | 4.88 | 6.71 | 241.75 | Upgrade
|
| Investing Cash Flow | - | -3,120 | -312.14 | 1,129 | 672.05 | 1,671 | Upgrade
|
| Long-Term Debt Issued | - | - | 1,732 | 199.99 | - | 7,541 | Upgrade
|
| Total Debt Issued | - | - | 1,732 | 199.99 | - | 7,541 | Upgrade
|
| Long-Term Debt Repaid | - | -2,085 | -1,098 | -2,048 | -1,251 | -10,441 | Upgrade
|
| Total Debt Repaid | - | -2,085 | -1,098 | -2,048 | -1,251 | -10,441 | Upgrade
|
| Net Debt Issued (Repaid) | - | -2,085 | 633.92 | -1,848 | -1,251 | -2,900 | Upgrade
|
| Issuance of Common Stock | - | 3,919 | - | - | - | 400 | Upgrade
|
| Other Financing Activities | - | -163.55 | -322.26 | -320.12 | -399.09 | -3.25 | Upgrade
|
| Financing Cash Flow | - | 1,670 | 311.66 | -2,168 | -1,650 | -2,503 | Upgrade
|
| Net Cash Flow | - | -189.96 | 182.91 | -113.87 | -741.98 | -24.19 | Upgrade
|
| Free Cash Flow | - | 611.77 | -665.75 | 780.71 | 229.82 | 765.61 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 239.71% | -69.98% | 1318.37% | Upgrade
|
| Free Cash Flow Margin | - | 7.47% | -10.00% | 13.95% | 5.11% | 15.82% | Upgrade
|
| Free Cash Flow Per Share | - | 12.65 | -16.31 | 19.13 | 5.63 | 1878.51 | Upgrade
|
| Cash Interest Paid | - | 163.55 | 322.26 | 320.12 | 399.09 | 3.25 | Upgrade
|
| Cash Income Tax Paid | - | -6.29 | 2.99 | 19.06 | -49.23 | -104.21 | Upgrade
|
| Levered Free Cash Flow | - | -2,498 | -1,048 | 2,206 | 100.7 | -3,992 | Upgrade
|
| Unlevered Free Cash Flow | - | -2,396 | -846.73 | 2,406 | 421.55 | -3,966 | Upgrade
|
| Change in Net Working Capital | - | 2,565 | 726.67 | -1,892 | 345.98 | 4,652 | Upgrade
|
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.